 | • レポートコード：B-GIR09D2737 • 出版社/出版日：GlobalInfoResearch / 2019年9月11日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医薬品・ヘルスケア |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、ポルフィリン症薬の世界市場について調べ、まとめました。種類別セグメントは、経口剤、注射剤等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。ポルフィリン症薬の世界市場概観、メーカー動向、メーカー別ポルフィリン症薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・ポルフィリン症薬の市場概観 ・ポルフィリン症薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ポルフィリン症薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・ポルフィリン症薬の世界市場規模 ・ポルフィリン症薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・ポルフィリン症薬のアメリカ市場規模推移 ・ポルフィリン症薬のカナダ市場規模推移 ・ポルフィリン症薬のメキシコ市場規模推移 ・ポルフィリン症薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・ポルフィリン症薬のドイツ市場規模推移 ・ポルフィリン症薬のイギリス市場規模推移 ・ポルフィリン症薬のロシア市場規模推移 ・ポルフィリン症薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・ポルフィリン症薬の日本市場規模推移 ・ポルフィリン症薬の中国市場規模推移 ・ポルフィリン症薬の韓国市場規模推移 ・ポルフィリン症薬のインド市場規模推移 ・ポルフィリン症薬の東南アジア市場規模推移 ・ポルフィリン症薬の南米市場分析（ブラジル、アルゼンチン等） ・ポルフィリン症薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・ポルフィリン症薬の種類別分析/販売量、売上、市場シェア（経口剤、注射剤） ・ポルフィリン症薬の用途別分析/市場規模（病院薬局、小売薬局、オンライン薬局） ・ポルフィリン症薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・ポルフィリン症薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Porphyria is a group of diseases in which substances called porphyrins build up, negatively affecting the skin or nervous system.
Scope of the Report:
The worldwide market for Porphyrias Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Porphyrias Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Lundbeck
Recordati Rare Diseases
Teva Pharmaceutical
Apotex
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Oral
Injectable
Market Segment by Applications, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Porphyrias Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Porphyrias Drugs, with price, sales, revenue and global market share of Porphyrias Drugs in 2017 and 2018.
Chapter 3, the Porphyrias Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Porphyrias Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Porphyrias Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Porphyrias Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Porphyrias Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Oral
1.2.2 Injectable
1.3 Market Analysis by Applications
1.3.1 Hospital Pharmacies
1.3.2 Retail Pharmacies
1.3.3 Online Pharmacies
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Lundbeck
2.1.1 Business Overview
2.1.2 Porphyrias Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Lundbeck Porphyrias Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Recordati Rare Diseases
2.2.1 Business Overview
2.2.2 Porphyrias Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Recordati Rare Diseases Porphyrias Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Teva Pharmaceutical
2.3.1 Business Overview
2.3.2 Porphyrias Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Teva Pharmaceutical Porphyrias Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Apotex
2.4.1 Business Overview
2.4.2 Porphyrias Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Apotex Porphyrias Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Porphyrias Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Porphyrias Drugs Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Porphyrias Drugs Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Porphyrias Drugs Manufacturer Market Share in 2018
3.3.2 Top 6 Porphyrias Drugs Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Porphyrias Drugs Market Analysis by Regions
4.1 Global Porphyrias Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Porphyrias Drugs Sales and Market Share by Regions (2014-2019)
4.1.2 Global Porphyrias Drugs Revenue and Market Share by Regions (2014-2019)
4.2 North America Porphyrias Drugs Sales and Growth Rate (2014-2019)
4.3 Europe Porphyrias Drugs Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Porphyrias Drugs Sales and Growth Rate (2014-2019)
4.5 South America Porphyrias Drugs Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Porphyrias Drugs Sales and Growth Rate (2014-2019)
5 North America Porphyrias Drugs by Country
5.1 North America Porphyrias Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Porphyrias Drugs Sales and Market Share by Country (2014-2019)
5.1.2 North America Porphyrias Drugs Revenue and Market Share by Country (2014-2019)
5.2 United States Porphyrias Drugs Sales and Growth Rate (2014-2019)
5.3 Canada Porphyrias Drugs Sales and Growth Rate (2014-2019)
5.4 Mexico Porphyrias Drugs Sales and Growth Rate (2014-2019)
6 Europe Porphyrias Drugs by Country
6.1 Europe Porphyrias Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Porphyrias Drugs Sales and Market Share by Country (2014-2019)
6.1.2 Europe Porphyrias Drugs Revenue and Market Share by Country (2014-2019)
6.2 Germany Porphyrias Drugs Sales and Growth Rate (2014-2019)
6.3 UK Porphyrias Drugs Sales and Growth Rate (2014-2019)
6.4 France Porphyrias Drugs Sales and Growth Rate (2014-2019)
6.5 Russia Porphyrias Drugs Sales and Growth Rate (2014-2019)
6.6 Italy Porphyrias Drugs Sales and Growth Rate (2014-2019)
7 Asia-Pacific Porphyrias Drugs by Country
7.1 Asia-Pacific Porphyrias Drugs Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Porphyrias Drugs Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Porphyrias Drugs Revenue and Market Share by Country (2014-2019)
7.2 China Porphyrias Drugs Sales and Growth Rate (2014-2019)
7.3 Japan Porphyrias Drugs Sales and Growth Rate (2014-2019)
7.4 Korea Porphyrias Drugs Sales and Growth Rate (2014-2019)
7.5 India Porphyrias Drugs Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Porphyrias Drugs Sales and Growth Rate (2014-2019)
8 South America Porphyrias Drugs by Country
8.1 South America Porphyrias Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Porphyrias Drugs Sales and Market Share by Country (2014-2019)
8.1.2 South America Porphyrias Drugs Revenue and Market Share by Country (2014-2019)
8.2 Brazil Porphyrias Drugs Sales and Growth Rate (2014-2019)
8.3 Argentina Porphyrias Drugs Sales and Growth Rate (2014-2019)
8.4 Colombia Porphyrias Drugs Sales and Growth Rate (2014-2019)
9 Middle East and Africa Porphyrias Drugs by Countries
9.1 Middle East and Africa Porphyrias Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Porphyrias Drugs Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Porphyrias Drugs Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Porphyrias Drugs Sales and Growth Rate (2014-2019)
9.3 Turkey Porphyrias Drugs Sales and Growth Rate (2014-2019)
9.4 Egypt Porphyrias Drugs Sales and Growth Rate (2014-2019)
9.5 Nigeria Porphyrias Drugs Sales and Growth Rate (2014-2019)
9.6 South Africa Porphyrias Drugs Sales and Growth Rate (2014-2019)
10 Global Porphyrias Drugs Market Segment by Type
10.1 Global Porphyrias Drugs Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Porphyrias Drugs Sales and Market Share by Type (2014-2019)
10.1.2 Global Porphyrias Drugs Revenue and Market Share by Type (2014-2019)
10.2 Oral Sales Growth and Price
10.2.1 Global Oral Sales Growth (2014-2019)
10.2.2 Global Oral Price (2014-2019)
10.3 Injectable Sales Growth and Price
10.3.1 Global Injectable Sales Growth (2014-2019)
10.3.2 Global Injectable Price (2014-2019)
11 Global Porphyrias Drugs Market Segment by Application
11.1 Global Porphyrias Drugs Sales Market Share by Application (2014-2019)
11.2 Hospital Pharmacies Sales Growth (2014-2019)
11.3 Retail Pharmacies Sales Growth (2014-2019)
11.4 Online Pharmacies Sales Growth (2014-2019)
12 Porphyrias Drugs Market Forecast (2019-2024)
12.1 Global Porphyrias Drugs Sales, Revenue and Growth Rate (2019-2024)
12.2 Porphyrias Drugs Market Forecast by Regions (2019-2024)
12.2.1 North America Porphyrias Drugs Market Forecast (2019-2024)
12.2.2 Europe Porphyrias Drugs Market Forecast (2019-2024)
12.2.3 Asia-Pacific Porphyrias Drugs Market Forecast (2019-2024)
12.2.4 South America Porphyrias Drugs Market Forecast (2019-2024)
12.2.5 Middle East and Africa Porphyrias Drugs Market Forecast (2019-2024)
12.3 Porphyrias Drugs Market Forecast by Type (2019-2024)
12.3.1 Global Porphyrias Drugs Sales Forecast by Type (2019-2024)
12.3.2 Global Porphyrias Drugs Market Share Forecast by Type (2019-2024)
12.4 Porphyrias Drugs Market Forecast by Application (2019-2024)
12.4.1 Global Porphyrias Drugs Sales Forecast by Application (2019-2024)
12.4.2 Global Porphyrias Drugs Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Porphyrias Drugs Picture
Table Product Specifications of Porphyrias Drugs
Figure Global Sales Market Share of Porphyrias Drugs by Types in 2018
Table Porphyrias Drugs Types for Major Manufacturers
Figure Oral Picture
Figure Injectable Picture
Figure Porphyrias Drugs Sales Market Share by Applications in 2018
Figure Hospital Pharmacies Picture
Figure Retail Pharmacies Picture
Figure Online Pharmacies Picture
Figure United States Porphyrias Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Porphyrias Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Porphyrias Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Porphyrias Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure France Porphyrias Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure UK Porphyrias Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Porphyrias Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Porphyrias Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure China Porphyrias Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Porphyrias Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Porphyrias Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure India Porphyrias Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Porphyrias Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Porphyrias Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Porphyrias Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Porphyrias Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Porphyrias Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Porphyrias Drugs Revenue (Value) and Growth Rate (2014-2024)
Table Lundbeck Basic Information, Manufacturing Base and Competitors
Table Lundbeck Porphyrias Drugs Type and Applications
Table Lundbeck Porphyrias Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Recordati Rare Diseases Basic Information, Manufacturing Base and Competitors
Table Recordati Rare Diseases Porphyrias Drugs Type and Applications
Table Recordati Rare Diseases Porphyrias Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Porphyrias Drugs Type and Applications
Table Teva Pharmaceutical Porphyrias Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Apotex Basic Information, Manufacturing Base and Competitors
Table Apotex Porphyrias Drugs Type and Applications
Table Apotex Porphyrias Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Porphyrias Drugs Sales by Manufacturer (2017-2018)
Figure Global Porphyrias Drugs Sales Market Share by Manufacturer in 2017
Figure Global Porphyrias Drugs Sales Market Share by Manufacturer in 2018
Table Global Porphyrias Drugs Revenue by Manufacturer (2017-2018)
Figure Global Porphyrias Drugs Revenue Market Share by Manufacturer in 2017
Figure Global Porphyrias Drugs Revenue Market Share by Manufacturer in 2018
Figure Top 3 Porphyrias Drugs Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Porphyrias Drugs Manufacturer (Revenue) Market Share in 2018
Figure Global Porphyrias Drugs Sales and Growth Rate (2014-2019)
Figure Global Porphyrias Drugs Revenue and Growth Rate (2014-2019)
Table Global Porphyrias Drugs Sales by Regions (2014-2019)
Table Global Porphyrias Drugs Sales Market Share by Regions (2014-2019)
Table Global Porphyrias Drugs Revenue by Regions (2014-2019)
Figure Global Porphyrias Drugs Revenue Market Share by Regions in 2014
Figure Global Porphyrias Drugs Revenue Market Share by Regions in 2018
Figure North America Porphyrias Drugs Sales and Growth Rate (2014-2019)
Figure Europe Porphyrias Drugs Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Porphyrias Drugs Sales and Growth Rate (2014-2019)
Figure South America Porphyrias Drugs Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Porphyrias Drugs Sales and Growth Rate (2014-2019)
Figure North America Porphyrias Drugs Revenue and Growth Rate (2014-2019)
Table North America Porphyrias Drugs Sales by Countries (2014-2019)
Table North America Porphyrias Drugs Sales Market Share by Countries (2014-2019)
Figure North America Porphyrias Drugs Sales Market Share by Countries in 2014
Figure North America Porphyrias Drugs Sales Market Share by Countries in 2018
Table North America Porphyrias Drugs Revenue by Countries (2014-2019)
Table North America Porphyrias Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Porphyrias Drugs Revenue Market Share by Countries in 2014
Figure North America Porphyrias Drugs Revenue Market Share by Countries in 2018
Figure United States Porphyrias Drugs Sales and Growth Rate (2014-2019)
Figure Canada Porphyrias Drugs Sales and Growth Rate (2014-2019)
Figure Mexico Porphyrias Drugs Sales and Growth Rate (2014-2019)
Figure Europe Porphyrias Drugs Revenue and Growth Rate (2014-2019)
Table Europe Porphyrias Drugs Sales by Countries (2014-2019)
Table Europe Porphyrias Drugs Sales Market Share by Countries (2014-2019)
Table Europe Porphyrias Drugs Revenue by Countries (2014-2019)
Figure Europe Porphyrias Drugs Revenue Market Share by Countries in 2017
Figure Europe Porphyrias Drugs Revenue Market Share by Countries in 2018
Figure Germany Porphyrias Drugs Sales and Growth Rate (2014-2019)
Figure UK Porphyrias Drugs Sales and Growth Rate (2014-2019)
Figure France Porphyrias Drugs Sales and Growth Rate (2014-2019)
Figure Russia Porphyrias Drugs Sales and Growth Rate (2014-2019)
Figure Italy Porphyrias Drugs Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Porphyrias Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Porphyrias Drugs Sales by Countries (2014-2019)
Table Asia-Pacific Porphyrias Drugs Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Porphyrias Drugs Sales Market Share by Countries 2018
Table Asia-Pacific Porphyrias Drugs Revenue by Countries (2014-2019)
Figure Asia-Pacific Porphyrias Drugs Revenue Market Share by Countries 2018
Figure China Porphyrias Drugs Sales and Growth Rate (2014-2019)
Figure Japan Porphyrias Drugs Sales and Growth Rate (2014-2019)
Figure Korea Porphyrias Drugs Sales and Growth Rate (2014-2019)
Figure India Porphyrias Drugs Sales and Growth Rate (2014-2019)
Figure Southeast Asia Porphyrias Drugs Sales and Growth Rate (2014-2019)
Figure South America Porphyrias Drugs Revenue and Growth Rate (2014-2019)
Table South America Porphyrias Drugs Sales by Countries (2014-2019)
Table South America Porphyrias Drugs Sales Market Share by Countries (2014-2019)
Figure South America Porphyrias Drugs Sales Market Share by Countries in 2018
Table South America Porphyrias Drugs Revenue by Countries (2014-2019)
Table South America Porphyrias Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Porphyrias Drugs Revenue Market Share by Countries in 2018
Figure Brazil Porphyrias Drugs Sales and Growth Rate (2014-2019)
Figure Argentina Porphyrias Drugs Sales and Growth Rate (2014-2019)
Figure Colombia Porphyrias Drugs Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Porphyrias Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Porphyrias Drugs Sales by Countries (2014-2019)
Table Middle East and Africa Porphyrias Drugs Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Porphyrias Drugs Sales Market Share by Countries in 2018
Table Middle East and Africa Porphyrias Drugs Revenue by Countries (2014-2019)
Table Middle East and Africa Porphyrias Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Porphyrias Drugs Revenue Market Share by Countries in 2014
Figure Middle East and Africa Porphyrias Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia Porphyrias Drugs Sales and Growth Rate (2014-2019)
Figure UAE Porphyrias Drugs Sales and Growth Rate (2014-2019)
Figure Egypt Porphyrias Drugs Sales and Growth Rate (2014-2019)
Figure Nigeria Porphyrias Drugs Sales and Growth Rate (2014-2019)
Figure South Africa Porphyrias Drugs Sales and Growth Rate (2014-2019)
Table Global Porphyrias Drugs Sales by Type (2014-2019)
Table Global Porphyrias Drugs Sales Share by Type (2014-2019)
Table Global Porphyrias Drugs Revenue by Type (2014-2019)
Table Global Porphyrias Drugs Revenue Share by Type (2014-2019)
Figure Global Oral Sales Growth (2014-2019)
Figure Global Oral Price (2014-2019)
Figure Global Injectable Sales Growth (2014-2019)
Figure Global Injectable Price (2014-2019)
Table Global Porphyrias Drugs Sales by Application (2014-2019)
Table Global Porphyrias Drugs Sales Share by Application (2014-2019)
Figure Global Retail Pharmacies Sales Growth (2014-2019)
Figure Global Online Pharmacies Sales Growth (2014-2019)
Figure Global Porphyrias Drugs Sales, Revenue and Growth Rate (2019-2024)
Table Global Porphyrias Drugs Sales Forecast by Regions (2019-2024)
Table Global Porphyrias Drugs Market Share Forecast by Regions (2019-2024)
Figure North America Sales Porphyrias Drugs Market Forecast (2019-2024)
Figure Europe Sales Porphyrias Drugs Market Forecast (2019-2024)
Figure Asia-Pacific Sales Porphyrias Drugs Market Forecast (2019-2024)
Figure South America Sales Porphyrias Drugs Market Forecast (2019-2024)
Figure Middle East and Africa Sales Porphyrias Drugs Market Forecast (2019-2024)
Table Global Porphyrias Drugs Sales Forecast by Type (2019-2024)
Table Global Porphyrias Drugs Market Share Forecast by Type (2019-2024)
Table Global Porphyrias Drugs Sales Forecast by Application (2019-2024)
Table Global Porphyrias Drugs Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
世界のポルフィリン症治療市場予測（～2024年） Porphyria is a group of diseases in which substances called porphyrins build up, negatively affecting the skin or nervous system. Scope of the Report: The global Porphyrias Treatments market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a …- 世界の腫瘍ジェネリック注射薬市場予測（～2024年） Generic drugs are essential in oncology because some anticancer drugs are only available as generics. Scope of the Report: The worldwide market for Oncology Generic Injectable Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx mill…
- 世界の粘膜類天疱瘡薬市場予測（～2024年） Mucous membrane pemphigoid is an autoimmune blistering disorder that is characterized by subepithelial bullae. Scope of the Report: The worldwide market for Mucous Membrane Pemphigoid Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from…
- 世界の抗線維化薬市場予測（～2024年） Dermal fibrosis is a fundamental feature of fatty skin sclerosis and is associated with increased levels of the cytokine transforming growth factor-β. This growth factor may derived from activated leukocytes, recruits macrophages and fibroblasts into the tissue and leads to the production of extrace…
- 世界のめまい薬市場予測（～2024年） Vertigo is a symptom of several different health conditions such as labyrinthitis and meniere's disease. Scope of the Report: The worldwide market for Vertigo Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, …